Background Instrumented knee laxity testing devices have been used in both the clinical and
research setting to evaluate persons with injuries about the knee. The ability to accurately …

… with ocrelizumab versus 55.1% with placebo (P=0.04); the total volume of … (P<0.001); and
the percentage of brain-volume loss was 0.90% with ocrelizumab versus 1.09% with placebo (P…

… The results in this study revealed an accumulation of higher concentration (p < 0.05) of bi-ligand
LPs in the brain of the experimental animals compared to both single-ligand bound LPs …

… trial 1 (94% lower number of lesions with ocrelizumab, P<0.001) and 0.02 versus 0.42 in trial
2 (95% lower number of lesions, P<0.001). The change in the Multiple Sclerosis Functional …

… QOL between continent and incontinent diversion (p = 0.31). Subgroup … (p = 0.002) compared
to continent diversions, but no differences in mental health (p = 0.35) and social health (p = …

… From baseline to week 96, rituximab patients had less (p < 0.001) increase in T2 lesion
volume; brain volume change was similar (p = 0.62) to placebo. Subgroup analysis showed time …

Allelic loss at the short arm of chromosome 3 is one of the most common and earliest events
in the pathogenesis of lung cancer, and is observed in more than 90% of small-cell lung …

The capabilities and physics models implemented inside the FLUKA code are briefly described,
with emphasis on hadronic interaction. Examples of the performances of the code are …

MRI detectable and targeted quantum dots were developed. To that aim, quantum dots were
coated with paramagnetic and pegylated lipids, which resulted in a relaxivity, r 1 , of nearly …

… The P values were determined by the Student t test. … If P value is <0.05, there is significant
difference between the two groups, unadjusted for multiple tests; if P value is <0.05*, the …